260 related articles for article (PubMed ID: 30908713)
1. Compromised Exercise Capacity and Mitochondrial Dysfunction in the Osteogenesis Imperfecta Murine (oim) Mouse Model.
Gremminger VL; Jeong Y; Cunningham RP; Meers GM; Rector RS; Phillips CL
J Bone Miner Res; 2019 Sep; 34(9):1646-1659. PubMed ID: 30908713
[TBL] [Abstract][Full Text] [Related]
2. Skeletal muscle specific mitochondrial dysfunction and altered energy metabolism in a murine model (oim/oim) of severe osteogenesis imperfecta.
Gremminger VL; Harrelson EN; Crawford TK; Ohler A; Schulz LC; Rector RS; Phillips CL
Mol Genet Metab; 2021 Apr; 132(4):244-253. PubMed ID: 33674196
[TBL] [Abstract][Full Text] [Related]
3. Skeletal muscle weakness in osteogenesis imperfecta mice.
Gentry BA; Ferreira JA; McCambridge AJ; Brown M; Phillips CL
Matrix Biol; 2010 Sep; 29(7):638-44. PubMed ID: 20619344
[TBL] [Abstract][Full Text] [Related]
4. Soluble activin receptor type IIB decoy receptor differentially impacts murine osteogenesis imperfecta muscle function.
Jeong Y; Daghlas SA; Kahveci AS; Salamango D; Gentry BA; Brown M; Rector RS; Pearsall RS; Phillips CL
Muscle Nerve; 2018 Feb; 57(2):294-304. PubMed ID: 28555931
[TBL] [Abstract][Full Text] [Related]
5. Skeletal muscle mitochondrial function and whole-body metabolic energetics in the +/G610C mouse model of osteogenesis imperfecta.
Gremminger VL; Omosule CL; Crawford TK; Cunningham R; Rector RS; Phillips CL
Mol Genet Metab; 2022 Aug; 136(4):315-323. PubMed ID: 35725939
[TBL] [Abstract][Full Text] [Related]
6. Myostatin deficiency partially rescues the bone phenotype of osteogenesis imperfecta model mice.
Oestreich AK; Carleton SM; Yao X; Gentry BA; Raw CE; Brown M; Pfeiffer FM; Wang Y; Phillips CL
Osteoporos Int; 2016 Jan; 27(1):161-70. PubMed ID: 26179666
[TBL] [Abstract][Full Text] [Related]
7. Skeletal Response to Soluble Activin Receptor Type IIB in Mouse Models of Osteogenesis Imperfecta.
Jeong Y; Daghlas SA; Xie Y; Hulbert MA; Pfeiffer FM; Dallas MR; Omosule CL; Pearsall RS; Dallas SL; Phillips CL
J Bone Miner Res; 2018 Oct; 33(10):1760-1772. PubMed ID: 29813187
[TBL] [Abstract][Full Text] [Related]
8. Are Changes in Composition in Response to Treatment of a Mouse Model of Osteogenesis Imperfecta Sex-dependent?
Boskey AL; Marino J; Spevak L; Pleshko N; Doty S; Carter EM; Raggio CL
Clin Orthop Relat Res; 2015 Aug; 473(8):2587-98. PubMed ID: 25903941
[TBL] [Abstract][Full Text] [Related]
9. Distinct type I collagen alterations cause intrinsic lung and respiratory defects of variable severity in mouse models of osteogenesis imperfecta.
Dimori M; Fett J; Leikin S; Otsuru S; Thostenson JD; Carroll JL; Morello R
J Physiol; 2023 Jan; 601(2):355-379. PubMed ID: 36285717
[TBL] [Abstract][Full Text] [Related]
10. Biomechanical, Microstructural and Material Properties of Tendon and Bone in the Young Oim Mice Model of Osteogenesis Imperfecta.
Chretien A; Couchot M; Mabilleau G; Behets C
Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077325
[TBL] [Abstract][Full Text] [Related]
11. OIM and related animal models of osteogenesis imperfecta.
Shapiro JR; Mcbride DJ; Fedarko NS
Connect Tissue Res; 1995; 31(4):265-8. PubMed ID: 15612365
[TBL] [Abstract][Full Text] [Related]
12. Hindlimb Skeletal Muscle Function and Skeletal Quality and Strength in +/G610C Mice With and Without Weight-Bearing Exercise.
Jeong Y; Carleton SM; Gentry BA; Yao X; Ferreira JA; Salamango DJ; Weis M; Oestreich AK; Williams AM; McCray MG; Eyre DR; Brown M; Wang Y; Phillips CL
J Bone Miner Res; 2015 Oct; 30(10):1874-86. PubMed ID: 25829218
[TBL] [Abstract][Full Text] [Related]
13. Decreasing maternal myostatin programs adult offspring bone strength in a mouse model of osteogenesis imperfecta.
Oestreich AK; Kamp WM; McCray MG; Carleton SM; Karasseva N; Lenz KL; Jeong Y; Daghlas SA; Yao X; Wang Y; Pfeiffer FM; Ellersieck MR; Schulz LC; Phillips CL
Proc Natl Acad Sci U S A; 2016 Nov; 113(47):13522-13527. PubMed ID: 27821779
[TBL] [Abstract][Full Text] [Related]
14. Osteogenesis Imperfecta: Muscle-Bone Interactions when Bi-directionally Compromised.
Phillips CL; Jeong Y
Curr Osteoporos Rep; 2018 Aug; 16(4):478-489. PubMed ID: 29909596
[TBL] [Abstract][Full Text] [Related]
15. Muscle-bone properties after prolonged voluntary wheel running in a mouse model of dominant severe osteogenesis imperfecta.
Tauer JT; Rigo Canevazzi GH; Schiettekatte-Maltais J; Rauch F; Bergeron R; Veilleux LN
J Musculoskelet Neuronal Interact; 2021 Dec; 21(4):517-527. PubMed ID: 34854391
[TBL] [Abstract][Full Text] [Related]
16. Increased cochlear otic capsule thickness and intracortical canal porosity in the oim mouse model of osteogenesis imperfecta.
De Paolis A; Miller BJ; Doube M; Bodey AJ; Rau C; Richter CP; Cardoso L; Carriero A
J Struct Biol; 2021 Jun; 213(2):107708. PubMed ID: 33581284
[TBL] [Abstract][Full Text] [Related]
17. Impact of Intrinsic Muscle Weakness on Muscle-Bone Crosstalk in Osteogenesis Imperfecta.
Gremminger VL; Phillips CL
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34066978
[TBL] [Abstract][Full Text] [Related]
18. Sclerostin antibody reduces long bone fractures in the oim/oim model of osteogenesis imperfecta.
Cardinal M; Tys J; Roels T; Lafont S; Ominsky MS; Devogelaer JP; Chappard D; Mabilleau G; Ammann P; Nyssen-Behets C; Manicourt DH
Bone; 2019 Jul; 124():137-147. PubMed ID: 31051315
[TBL] [Abstract][Full Text] [Related]
19. Sclerostin-Antibody Treatment Decreases Fracture Rates in Axial Skeleton and Improves the Skeletal Phenotype in Growing oim/oim Mice.
Cardinal M; Dessain A; Roels T; Lafont S; Ominsky MS; Devogelaer JP; Chappard D; Mabilleau G; Ammann P; Nyssen-Behets C; Manicourt DH
Calcif Tissue Int; 2020 May; 106(5):494-508. PubMed ID: 32025752
[TBL] [Abstract][Full Text] [Related]
20. Dysfunction of Caveolae-Mediated Endocytic TβRI Degradation Results in Hypersensitivity of TGF-β/Smad Signaling in Osteogenesis Imperfecta.
Shi C; Sun B; Wu H; Zhang R; Wu L; Guo L; Li C; Xi Y; Yuan W; Zhang Y; Xu G
J Bone Miner Res; 2023 Jan; 38(1):103-118. PubMed ID: 36321807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
